Swiss pharmaceutical giant Novartis has raised its full-year earnings forecast, citing robust revenue growth from key products, including its breast cancer drug Kisqali, during a strong second quarter. The company also announced a substantial share buyback program, signaling confidence in its future growth trajectory, alongside news of its long-serving Chief…
European stock markets are set to open higher on Thursday, with positive momentum fueled by a strong earnings report…
Russia’s wheat harvest has plummeted to half of last year’s output, according to SovEcon, raising concerns about global grain…
The EasyJet share price faced turbulence on Thursday after the company published weaker-than-expected earnings. It plunged to a low…
A significant upward revision to May’s payroll figures, coupled with Wednesday’s hotter-than-expected inflation data, is easing the pressure on…
Volvo Cars has reported a group operating profit (EBIT) of SEK -10.0 billion for the second quarter of 2025,…
A quiet town in Maharashtra found itself in an international spotlight this week.Kolhapur, famed for its traditional leather chappals…
Asian equity markets rose broadly on Thursday as investor sentiment improved following US President Donald Trump’s comments downplaying the…
Shares of PepsiCo Inc. climbed in premarket trading on Thursday after the snack and beverage giant reported a better-than-expected…